178 related articles for article (PubMed ID: 31152746)
1. A Spray-Dried Combination of Capreomycin and CPZEN-45 for Inhaled Tuberculosis Therapy.
Pitner RA; Durham PG; Stewart IE; Reed SG; Cassell GH; Hickey AJ; Carter D
J Pharm Sci; 2019 Oct; 108(10):3302-3311. PubMed ID: 31152746
[TBL] [Abstract][Full Text] [Related]
2. Optimization and Scale Up of Spray Dried CPZEN-45 Aerosol Powders for Inhaled Tuberculosis Treatment.
Stewart IE; Durham PG; Sittenauer JM; Barreda AP; Stowell GW; Moody C; Mecham JB; Simpson C; Daily S; Maloney SE; Williams MD; Severynse-Stevens D; Hickey AJ
Pharm Res; 2022 Dec; 39(12):3359-3370. PubMed ID: 36114362
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin.
Fiegel J; Garcia-Contreras L; Thomas M; VerBerkmoes J; Elbert K; Hickey A; Edwards D
Pharm Res; 2008 Apr; 25(4):805-11. PubMed ID: 17657592
[TBL] [Abstract][Full Text] [Related]
4. Powder, capsule and device: An imperative ménage à trois for respirable dry powders.
Schoubben A; Blasi P; Giontella A; Giovagnoli S; Ricci M
Int J Pharm; 2015 Oct; 494(1):40-8. PubMed ID: 26255220
[TBL] [Abstract][Full Text] [Related]
5. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
Eedara BB; Tucker IG; Das SC
Int J Pharm; 2016 Jun; 506(1-2):174-83. PubMed ID: 27091294
[TBL] [Abstract][Full Text] [Related]
6. Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis.
Shao Z; Chow MYT; Chow SF; Lam JKW
Pharm Res; 2023 May; 40(5):1073-1086. PubMed ID: 36869245
[TBL] [Abstract][Full Text] [Related]
7. Capreomycin inhalable powders prepared with an innovative spray-drying technique.
Schoubben A; Giovagnoli S; Tiralti MC; Blasi P; Ricci M
Int J Pharm; 2014 Jul; 469(1):132-9. PubMed ID: 24747443
[TBL] [Abstract][Full Text] [Related]
8. Simple and scalable method for peptide inhalable powder production.
Schoubben A; Blasi P; Giovagnoli S; Ricci M; Rossi C
Eur J Pharm Sci; 2010 Jan; 39(1-3):53-8. PubMed ID: 19879945
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of Ethionamide Delivered in Spray-Dried Microparticles to the Lungs of Guinea Pigs.
Garcia-Contreras L; Padilla-Carlin DJ; Sung J; VerBerkmoes J; Muttil P; Elbert K; Peloquin C; Edwards D; Hickey A
J Pharm Sci; 2017 Jan; 106(1):331-337. PubMed ID: 27842973
[TBL] [Abstract][Full Text] [Related]
10. Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis.
Rangnekar B; Momin MAM; Eedara BB; Sinha S; Das SC
Int J Pharm; 2019 Oct; 570():118689. PubMed ID: 31513868
[TBL] [Abstract][Full Text] [Related]
11. Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosis.
Momin MAM; Sinha S; Tucker IG; Das SC
Drug Dev Ind Pharm; 2019 Aug; 45(8):1321-1331. PubMed ID: 31014129
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of sequential doses of capreomycin powder for inhalation in guinea pigs.
Garcia-Contreras L; Muttil P; Fallon JK; Kabadi M; Gerety R; Hickey AJ
Antimicrob Agents Chemother; 2012 May; 56(5):2612-8. PubMed ID: 22330920
[TBL] [Abstract][Full Text] [Related]
13. Phase I, single-dose, dose-escalating study of inhaled dry powder capreomycin: a new approach to therapy of drug-resistant tuberculosis.
Dharmadhikari AS; Kabadi M; Gerety B; Hickey AJ; Fourie PB; Nardell E
Antimicrob Agents Chemother; 2013 Jun; 57(6):2613-9. PubMed ID: 23529740
[TBL] [Abstract][Full Text] [Related]
14. Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model.
Garcia-Contreras L; Fiegel J; Telko MJ; Elbert K; Hawi A; Thomas M; VerBerkmoes J; Germishuizen WA; Fourie PB; Hickey AJ; Edwards D
Antimicrob Agents Chemother; 2007 Aug; 51(8):2830-6. PubMed ID: 17517845
[TBL] [Abstract][Full Text] [Related]
15. A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics.
Chan JG; Chan HK; Prestidge CA; Denman JA; Young PM; Traini D
Eur J Pharm Biopharm; 2013 Feb; 83(2):285-92. PubMed ID: 22982733
[TBL] [Abstract][Full Text] [Related]
16. Inhaled dry powder formulations for treating tuberculosis.
Das S; Tucker I; Stewart P
Curr Drug Deliv; 2015; 12(1):26-39. PubMed ID: 25030114
[TBL] [Abstract][Full Text] [Related]
17. Spray Dried Aerosol Particles of Pyrazinoic Acid Salts for Tuberculosis Therapy. [Corrected].
Durham PG; Zhang Y; German N; Mortensen N; Dhillon J; Mitchison DA; Fourie PB; Hickey AJ
Mol Pharm; 2015 Aug; 12(8):2574-81. PubMed ID: 26098136
[TBL] [Abstract][Full Text] [Related]
18. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of Inhaled Rifampicin Porous Particles for Tuberculosis Treatment: Insight into Rifampicin Absorption from the Lungs of Guinea Pigs.
Garcia Contreras L; Sung J; Ibrahim M; Elbert K; Edwards D; Hickey A
Mol Pharm; 2015 Aug; 12(8):2642-50. PubMed ID: 25942002
[TBL] [Abstract][Full Text] [Related]
20. Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles.
Weers JG; Miller DP; Tarara TE
AAPS PharmSciTech; 2019 Feb; 20(3):103. PubMed ID: 30734187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
